Trial · NCT03296527
Results by group242
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 242
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Ongoing Pregnancy Rate | FE 000049 (Follitropin Delta) | 31.3 | percentage of participants | ||
| Ongoing Pregnancy Rate | GONAL-F (Follitropin Alfa) | 25.7 | percentage of participants | ||
| Positive Beta Unit of Human Chorionic Gonadotropin (βhCG) Rate | FE 000049 (Follitropin Delta) | 41.7 | percentage of participants | ||
| Positive Beta Unit of Human Chorionic Gonadotropin (βhCG) Rate | GONAL-F (Follitropin Alfa) | 35.3 | percentage of participants | ||
| Clinical Pregnancy Rate | FE 000049 (Follitropin Delta) | 36.1 | percentage of participants | ||
| Clinical Pregnancy Rate | GONAL-F (Follitropin Alfa) | 31.2 | percentage of participants | ||
| Vital Pregnancy Rate | FE 000049 (Follitropin Delta) | 32.3 | percentage of participants | ||
| Vital Pregnancy Rate | GONAL-F (Follitropin Alfa) | 28.0 | percentage of participants | ||
| Implantation Rate | FE 000049 (Follitropin Delta) | 35.6 | percentage of sacs/embryos transferred | ||
| Implantation Rate | GONAL-F (Follitropin Alfa) | 31.3 | percentage of sacs/embryos transferred | ||
| Ongoing Implantation Rate | FE 000049 (Follitropin Delta) | 30.7 | % of viable fetus/embryos transferred | ||
| Ongoing Implantation Rate | GONAL-F (Follitropin Alfa) | 25.8 | % of viable fetus/embryos transferred | ||
| Proportion of Subjects With Extreme Ovarian Responses | FE 000049 (Follitropin Delta) | <4 or >=15 oocytes retrieved | 30.3 | percentage of participants | |
| Proportion of Subjects With Extreme Ovarian Responses | GONAL-F (Follitropin Alfa) | <4 or >=15 oocytes retrieved | 35.1 | percentage of participants | |
| Proportion of Subjects With Extreme Ovarian Responses | FE 000049 (Follitropin Delta) | <4 or >=20 oocytes retrieved | 17.4 | percentage of participants | |
| Proportion of Subjects With Extreme Ovarian Responses | GONAL-F (Follitropin Alfa) | <4 or >=20 oocytes retrieved | 18.9 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FE 000049 (Follitropin Delta) | Early OHSS (any grade) | 4.0 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | GONAL-F (Follitropin Alfa) | Early OHSS (any grade) | 6.5 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FE 000049 (Follitropin Delta) | Early OHSS (moderate/severe) | 3.6 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | GONAL-F (Follitropin Alfa) | Early OHSS (moderate/severe) | 4.7 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03296527/results